Low venous thromboembolism incidence in high risk medical patients in an Israeli hospital. Can risk assessment be extrapolated to different populations?
Guidelines recommend venous thromboembolism (VTE) prophylaxis in hospitalized medical patients with Padua prediction score (PPS) [greater than or equal to]4 points. This recommendation is based on the high risk of symptomatic VTE observed among these patients in the Italian PPS derivation study, and...
Gespeichert in:
| Veröffentlicht in: | PloS one 2020-07, Vol.15 (7), p.e0235683-e0235683 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e0235683 |
|---|---|
| container_issue | 7 |
| container_start_page | e0235683 |
| container_title | PloS one |
| container_volume | 15 |
| creator | Koren, Ofir Nasser, Arin Elias, Mazen Avraham, Gilat Freidberg, Nahum Saliba, Walid Goldstein, Lee H Serra, Raffaele |
| description | Guidelines recommend venous thromboembolism (VTE) prophylaxis in hospitalized medical patients with Padua prediction score (PPS) [greater than or equal to]4 points. This recommendation is based on the high risk of symptomatic VTE observed among these patients in the Italian PPS derivation study, and the fivefold risk reduction with VTE-prophylaxis. This study aims to assess the incidence of VTE in high risk medical patients in a medium sized hospital in Israel. In this retrospective cohort study, data was collected of all medical patients hospitalized between January and June 2014. Patients were classified into low and high risk groups according to their PPS score, and according to whether they received anticoagulant thromboprophylaxis for VTE. Patients were further randomly selected to compare high risk patients that did or did not receive anticoagulant thromboprophylaxis. We further compared VTE incidence in high and low risk patients not treated with thromboprophylaxis. A search was conducted for diagnoses of venous thromboembolism and death during hospitalization and the following 90 days. 568 high risk patients (PPS [greater than or equal to]4 points) were included, 284 treated with prophylactic anticoagulation and 284 not. There were no VTE events in either group. There was no difference in mortality. A total of 642 non anticoagulated patients were randomly selected, 474 low risk and 168 high risk. There were no VTE events in either group. The risk of VTE appears to be very low in our study, suggesting that among medical patients with PPS [greater than or equal to]4, the risk of VTE may differ dramatically between populations. |
| doi_str_mv | 10.1371/journal.pone.0235683 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2420594104</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A628712490</galeid><doaj_id>oai_doaj_org_article_80758ece5ae34464b8eebe63fa098dce</doaj_id><sourcerecordid>A628712490</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5843-bcb4d48e0ee2b2f8d625dcf50004f6fbf62df4a3add15f16f00a455d52ed62023</originalsourceid><addsrcrecordid>eNqNk22L1DAQx4so3nn6DQQDguiLXdM8dLtvlGPxYWHhwKe3IU0m26xpU5P21G_ixzXdrXKVeyElNMz85j-ZSSbLHud4mdNV_vLgh9BKt-x8C0tMKC9Keic7z9eULAqC6d0b-7PsQYwHjDkti-J-dkZJQcoV4efZr53_jq6h9UNEfR18U3lIy9nYINsqq6FVkHaotvsaBRu_oga0VdKhTvYW2j6OXtmibQwSnEW1j53t08HQJlmPETJGiLFJMKoAwY8-yM472YNGvUfaGgNhdHa-G5LZ-ja-fpjdM9JFeDT9L7LPb9982rxf7K7ebTeXu4XiJaOLSlVMsxIwAKmIKXVBuFaGY4yZKUxlCqINk1RqnXOTFwZjyTjXnEBCU9susicn3c75KKamRkEYwXzNcswSsT0R2suD6IJtZPgpvLTiaPBhL2TorXIgSrziJSjgEihjBatKgAoKaiRel1pB0no1ZRuq1EeVqg7SzUTnntbWYu-vxYrSFSlxEng-CQT_bYDYi8ZGBc7JFtIdjufOc0IxyxP69B_09uomai9TAbY1PuVVo6i4HB9JTth6TLu8hUqfhsaq9AKNTfZZwItZQGL6dPF7OcQoth8__D979WXOPrvB1iBdX0fvhuOjmYPsBKrgYwxg_jY5x2IcoD_dEOMAiWmA6G9dOQ-o</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2420594104</pqid></control><display><type>article</type><title>Low venous thromboembolism incidence in high risk medical patients in an Israeli hospital. Can risk assessment be extrapolated to different populations?</title><source>Public Library of Science (PLoS) Journals Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Koren, Ofir ; Nasser, Arin ; Elias, Mazen ; Avraham, Gilat ; Freidberg, Nahum ; Saliba, Walid ; Goldstein, Lee H ; Serra, Raffaele</creator><contributor>Serra, Raffaele</contributor><creatorcontrib>Koren, Ofir ; Nasser, Arin ; Elias, Mazen ; Avraham, Gilat ; Freidberg, Nahum ; Saliba, Walid ; Goldstein, Lee H ; Serra, Raffaele ; Serra, Raffaele</creatorcontrib><description>Guidelines recommend venous thromboembolism (VTE) prophylaxis in hospitalized medical patients with Padua prediction score (PPS) [greater than or equal to]4 points. This recommendation is based on the high risk of symptomatic VTE observed among these patients in the Italian PPS derivation study, and the fivefold risk reduction with VTE-prophylaxis. This study aims to assess the incidence of VTE in high risk medical patients in a medium sized hospital in Israel. In this retrospective cohort study, data was collected of all medical patients hospitalized between January and June 2014. Patients were classified into low and high risk groups according to their PPS score, and according to whether they received anticoagulant thromboprophylaxis for VTE. Patients were further randomly selected to compare high risk patients that did or did not receive anticoagulant thromboprophylaxis. We further compared VTE incidence in high and low risk patients not treated with thromboprophylaxis. A search was conducted for diagnoses of venous thromboembolism and death during hospitalization and the following 90 days. 568 high risk patients (PPS [greater than or equal to]4 points) were included, 284 treated with prophylactic anticoagulation and 284 not. There were no VTE events in either group. There was no difference in mortality. A total of 642 non anticoagulated patients were randomly selected, 474 low risk and 168 high risk. There were no VTE events in either group. The risk of VTE appears to be very low in our study, suggesting that among medical patients with PPS [greater than or equal to]4, the risk of VTE may differ dramatically between populations.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0235683</identifier><identifier>PMID: 32628725</identifier><language>eng</language><publisher>San Francisco: Public Library of Science</publisher><subject>Anticoagulants ; Biology and Life Sciences ; Drug dosages ; Health services ; Hospital patients ; Hospitalization ; Hospitals ; Internal medicine ; Medicine ; Medicine and Health Sciences ; Molecular weight ; Mortality ; Patients ; People and Places ; Populations ; Prognosis ; Prophylaxis ; Pulmonary embolisms ; Risk assessment ; Risk factors ; Risk groups ; Risk management ; Risk reduction ; Sample size ; Statistics ; Thromboembolism ; Thrombosis ; Veins & arteries ; Venous thrombosis</subject><ispartof>PloS one, 2020-07, Vol.15 (7), p.e0235683-e0235683</ispartof><rights>COPYRIGHT 2020 Public Library of Science</rights><rights>2020 Koren et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 Koren et al 2020 Koren et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5843-bcb4d48e0ee2b2f8d625dcf50004f6fbf62df4a3add15f16f00a455d52ed62023</citedby><cites>FETCH-LOGICAL-c5843-bcb4d48e0ee2b2f8d625dcf50004f6fbf62df4a3add15f16f00a455d52ed62023</cites><orcidid>0000-0002-8666-8276</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337280/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337280/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79343,79344</link.rule.ids></links><search><contributor>Serra, Raffaele</contributor><creatorcontrib>Koren, Ofir</creatorcontrib><creatorcontrib>Nasser, Arin</creatorcontrib><creatorcontrib>Elias, Mazen</creatorcontrib><creatorcontrib>Avraham, Gilat</creatorcontrib><creatorcontrib>Freidberg, Nahum</creatorcontrib><creatorcontrib>Saliba, Walid</creatorcontrib><creatorcontrib>Goldstein, Lee H</creatorcontrib><creatorcontrib>Serra, Raffaele</creatorcontrib><title>Low venous thromboembolism incidence in high risk medical patients in an Israeli hospital. Can risk assessment be extrapolated to different populations?</title><title>PloS one</title><description>Guidelines recommend venous thromboembolism (VTE) prophylaxis in hospitalized medical patients with Padua prediction score (PPS) [greater than or equal to]4 points. This recommendation is based on the high risk of symptomatic VTE observed among these patients in the Italian PPS derivation study, and the fivefold risk reduction with VTE-prophylaxis. This study aims to assess the incidence of VTE in high risk medical patients in a medium sized hospital in Israel. In this retrospective cohort study, data was collected of all medical patients hospitalized between January and June 2014. Patients were classified into low and high risk groups according to their PPS score, and according to whether they received anticoagulant thromboprophylaxis for VTE. Patients were further randomly selected to compare high risk patients that did or did not receive anticoagulant thromboprophylaxis. We further compared VTE incidence in high and low risk patients not treated with thromboprophylaxis. A search was conducted for diagnoses of venous thromboembolism and death during hospitalization and the following 90 days. 568 high risk patients (PPS [greater than or equal to]4 points) were included, 284 treated with prophylactic anticoagulation and 284 not. There were no VTE events in either group. There was no difference in mortality. A total of 642 non anticoagulated patients were randomly selected, 474 low risk and 168 high risk. There were no VTE events in either group. The risk of VTE appears to be very low in our study, suggesting that among medical patients with PPS [greater than or equal to]4, the risk of VTE may differ dramatically between populations.</description><subject>Anticoagulants</subject><subject>Biology and Life Sciences</subject><subject>Drug dosages</subject><subject>Health services</subject><subject>Hospital patients</subject><subject>Hospitalization</subject><subject>Hospitals</subject><subject>Internal medicine</subject><subject>Medicine</subject><subject>Medicine and Health Sciences</subject><subject>Molecular weight</subject><subject>Mortality</subject><subject>Patients</subject><subject>People and Places</subject><subject>Populations</subject><subject>Prognosis</subject><subject>Prophylaxis</subject><subject>Pulmonary embolisms</subject><subject>Risk assessment</subject><subject>Risk factors</subject><subject>Risk groups</subject><subject>Risk management</subject><subject>Risk reduction</subject><subject>Sample size</subject><subject>Statistics</subject><subject>Thromboembolism</subject><subject>Thrombosis</subject><subject>Veins & arteries</subject><subject>Venous thrombosis</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk22L1DAQx4so3nn6DQQDguiLXdM8dLtvlGPxYWHhwKe3IU0m26xpU5P21G_ixzXdrXKVeyElNMz85j-ZSSbLHud4mdNV_vLgh9BKt-x8C0tMKC9Keic7z9eULAqC6d0b-7PsQYwHjDkti-J-dkZJQcoV4efZr53_jq6h9UNEfR18U3lIy9nYINsqq6FVkHaotvsaBRu_oga0VdKhTvYW2j6OXtmibQwSnEW1j53t08HQJlmPETJGiLFJMKoAwY8-yM472YNGvUfaGgNhdHa-G5LZ-ja-fpjdM9JFeDT9L7LPb9982rxf7K7ebTeXu4XiJaOLSlVMsxIwAKmIKXVBuFaGY4yZKUxlCqINk1RqnXOTFwZjyTjXnEBCU9susicn3c75KKamRkEYwXzNcswSsT0R2suD6IJtZPgpvLTiaPBhL2TorXIgSrziJSjgEihjBatKgAoKaiRel1pB0no1ZRuq1EeVqg7SzUTnntbWYu-vxYrSFSlxEng-CQT_bYDYi8ZGBc7JFtIdjufOc0IxyxP69B_09uomai9TAbY1PuVVo6i4HB9JTth6TLu8hUqfhsaq9AKNTfZZwItZQGL6dPF7OcQoth8__D979WXOPrvB1iBdX0fvhuOjmYPsBKrgYwxg_jY5x2IcoD_dEOMAiWmA6G9dOQ-o</recordid><startdate>20200706</startdate><enddate>20200706</enddate><creator>Koren, Ofir</creator><creator>Nasser, Arin</creator><creator>Elias, Mazen</creator><creator>Avraham, Gilat</creator><creator>Freidberg, Nahum</creator><creator>Saliba, Walid</creator><creator>Goldstein, Lee H</creator><creator>Serra, Raffaele</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-8666-8276</orcidid></search><sort><creationdate>20200706</creationdate><title>Low venous thromboembolism incidence in high risk medical patients in an Israeli hospital. Can risk assessment be extrapolated to different populations?</title><author>Koren, Ofir ; Nasser, Arin ; Elias, Mazen ; Avraham, Gilat ; Freidberg, Nahum ; Saliba, Walid ; Goldstein, Lee H ; Serra, Raffaele</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5843-bcb4d48e0ee2b2f8d625dcf50004f6fbf62df4a3add15f16f00a455d52ed62023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Anticoagulants</topic><topic>Biology and Life Sciences</topic><topic>Drug dosages</topic><topic>Health services</topic><topic>Hospital patients</topic><topic>Hospitalization</topic><topic>Hospitals</topic><topic>Internal medicine</topic><topic>Medicine</topic><topic>Medicine and Health Sciences</topic><topic>Molecular weight</topic><topic>Mortality</topic><topic>Patients</topic><topic>People and Places</topic><topic>Populations</topic><topic>Prognosis</topic><topic>Prophylaxis</topic><topic>Pulmonary embolisms</topic><topic>Risk assessment</topic><topic>Risk factors</topic><topic>Risk groups</topic><topic>Risk management</topic><topic>Risk reduction</topic><topic>Sample size</topic><topic>Statistics</topic><topic>Thromboembolism</topic><topic>Thrombosis</topic><topic>Veins & arteries</topic><topic>Venous thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koren, Ofir</creatorcontrib><creatorcontrib>Nasser, Arin</creatorcontrib><creatorcontrib>Elias, Mazen</creatorcontrib><creatorcontrib>Avraham, Gilat</creatorcontrib><creatorcontrib>Freidberg, Nahum</creatorcontrib><creatorcontrib>Saliba, Walid</creatorcontrib><creatorcontrib>Goldstein, Lee H</creatorcontrib><creatorcontrib>Serra, Raffaele</creatorcontrib><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koren, Ofir</au><au>Nasser, Arin</au><au>Elias, Mazen</au><au>Avraham, Gilat</au><au>Freidberg, Nahum</au><au>Saliba, Walid</au><au>Goldstein, Lee H</au><au>Serra, Raffaele</au><au>Serra, Raffaele</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low venous thromboembolism incidence in high risk medical patients in an Israeli hospital. Can risk assessment be extrapolated to different populations?</atitle><jtitle>PloS one</jtitle><date>2020-07-06</date><risdate>2020</risdate><volume>15</volume><issue>7</issue><spage>e0235683</spage><epage>e0235683</epage><pages>e0235683-e0235683</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Guidelines recommend venous thromboembolism (VTE) prophylaxis in hospitalized medical patients with Padua prediction score (PPS) [greater than or equal to]4 points. This recommendation is based on the high risk of symptomatic VTE observed among these patients in the Italian PPS derivation study, and the fivefold risk reduction with VTE-prophylaxis. This study aims to assess the incidence of VTE in high risk medical patients in a medium sized hospital in Israel. In this retrospective cohort study, data was collected of all medical patients hospitalized between January and June 2014. Patients were classified into low and high risk groups according to their PPS score, and according to whether they received anticoagulant thromboprophylaxis for VTE. Patients were further randomly selected to compare high risk patients that did or did not receive anticoagulant thromboprophylaxis. We further compared VTE incidence in high and low risk patients not treated with thromboprophylaxis. A search was conducted for diagnoses of venous thromboembolism and death during hospitalization and the following 90 days. 568 high risk patients (PPS [greater than or equal to]4 points) were included, 284 treated with prophylactic anticoagulation and 284 not. There were no VTE events in either group. There was no difference in mortality. A total of 642 non anticoagulated patients were randomly selected, 474 low risk and 168 high risk. There were no VTE events in either group. The risk of VTE appears to be very low in our study, suggesting that among medical patients with PPS [greater than or equal to]4, the risk of VTE may differ dramatically between populations.</abstract><cop>San Francisco</cop><pub>Public Library of Science</pub><pmid>32628725</pmid><doi>10.1371/journal.pone.0235683</doi><tpages>e0235683</tpages><orcidid>https://orcid.org/0000-0002-8666-8276</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1932-6203 |
| ispartof | PloS one, 2020-07, Vol.15 (7), p.e0235683-e0235683 |
| issn | 1932-6203 1932-6203 |
| language | eng |
| recordid | cdi_plos_journals_2420594104 |
| source | Public Library of Science (PLoS) Journals Open Access; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry |
| subjects | Anticoagulants Biology and Life Sciences Drug dosages Health services Hospital patients Hospitalization Hospitals Internal medicine Medicine Medicine and Health Sciences Molecular weight Mortality Patients People and Places Populations Prognosis Prophylaxis Pulmonary embolisms Risk assessment Risk factors Risk groups Risk management Risk reduction Sample size Statistics Thromboembolism Thrombosis Veins & arteries Venous thrombosis |
| title | Low venous thromboembolism incidence in high risk medical patients in an Israeli hospital. Can risk assessment be extrapolated to different populations? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T01%3A04%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low%20venous%20thromboembolism%20incidence%20in%20high%20risk%20medical%20patients%20in%20an%20Israeli%20hospital.%20Can%20risk%20assessment%20be%20extrapolated%20to%20different%20populations?&rft.jtitle=PloS%20one&rft.au=Koren,%20Ofir&rft.date=2020-07-06&rft.volume=15&rft.issue=7&rft.spage=e0235683&rft.epage=e0235683&rft.pages=e0235683-e0235683&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0235683&rft_dat=%3Cgale_plos_%3EA628712490%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2420594104&rft_id=info:pmid/32628725&rft_galeid=A628712490&rft_doaj_id=oai_doaj_org_article_80758ece5ae34464b8eebe63fa098dce&rfr_iscdi=true |